Literature DB >> 10514127

Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali).

G Meucci1, A Bortoli, F A Riccioli, C M Girelli, F Radaelli, R Rivolta, M Tatarella.   

Abstract

OBJECTIVE: To evaluate the prevalence and the clinical evolution of patients with an initial diagnosis of indeterminate colitis.
DESIGN: Retrospective, observational study.
SETTING: Fifteen gastrointestinal units in northern Italy. PARTICIPANTS: Patients with an initial diagnosis of indeterminate colitis seen between 1988 and 1993.
INTERVENTIONS: Patients were traced through a common database and centres were requested to update their clinical follow-up. MAIN OUTCOME MEASURES: Frequency of patients with an initial diagnosis of indeterminate colitis among those with IBD; rate of patients who subsequently had a definite diagnosis of either Crohn's disease or ulcerative colitis.
RESULTS: Fifty out of 1113 IBD patients (4.6%) had been diagnosed as having indeterminate colitis. During follow-up, 37 patients (72.5%) had a definite diagnosis of either Crohn's disease or ulcerative colitis. The cumulative probability of having a definite diagnosis of either ulcerative colitis or Crohn's disease was 80% 8 years after the first one (i.e. the first diagnosis). The probability of having a diagnosis of Crohn's disease was increased in patients with fever at onset, segmental endoscopic lesions or extra-intestinal complications and in current smokers. The probability of having a diagnosis of ulcerative colitis was increased in patients who had not undergone appendectomy before diagnosis.
CONCLUSIONS: In our area, indeterminate colitis accounts for about 5% of initial diagnoses of IBD. In about 80% of patients, a diagnosis of either ulcerative colitis or Crohn's disease is made within 8 years. Several clinical and demographic features can help in identifying those patients more likely to have a subsequent diagnosis of Crohn's disease and those more likely to have a subsequent diagnosis of ulcerative colitis.

Entities:  

Mesh:

Year:  1999        PMID: 10514127

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  16 in total

Review 1.  Indeterminate colitis.

Authors:  M Guindi; R H Riddell
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

Review 2.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 3.  Indeterminate colitis.

Authors:  P J Mitchell; M Y Rabau; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-05-25       Impact factor: 3.781

Review 4.  The endoscopic findings of the upper gastrointestinal tract in patients with Crohn's disease.

Authors:  Yoshiki Nomura; Kentaro Moriichi; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Clin J Gastroenterol       Date:  2017-07-10

Review 5.  Diagnostic dilemmas in chronic inflammatory bowel disease.

Authors:  Maurice B Loughrey; Neil A Shepherd
Journal:  Virchows Arch       Date:  2017-11-04       Impact factor: 4.064

6.  Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis.

Authors:  Billy Ray Ballard; Amosy Ephreim M'Koma
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

7.  Inflammatory bowel disease unclassified.

Authors:  Ning Zhou; Wei-xing Chen; Shao-hua Chen; Cheng-fu Xu; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2011-04       Impact factor: 3.066

8.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

9.  Atypical pANCA as a marker of indeterminate colitis for the prediction of ulcerative colitis and Crohn's disease.

Authors:  Murat Kekilli; Yavuz Beyazit; Adnan Tas; Bilge Tunc; Abdurrahim Sayilir; Aysel Ulker
Journal:  Wien Klin Wochenschr       Date:  2013-04-26       Impact factor: 1.704

Review 10.  MicroRNA in inflammatory bowel disease: Translational research and clinical implication.

Authors:  Kurt Fisher; Jingmei Lin
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.